A provider of artificial intelligence services for scientific and advanced technology applications is raising $100 million in its second venture round. . . . → Read More: Science/Tech AI Developer Raises $100M in New Funds
|
|||||
       
  |
A new not-for-profit organization aims to create a more efficient process for large-scale randomized clinical trials, to provide reliable results at lower cost. . . . → Read More: Group Devising Lower Cost Clinical Trials 
A developer of Covid-19 vaccines and an artificial intelligence company are building a system to quickly detect dangerous SARS-CoV-2 variants. . . . → Read More: Biotech, AI Company Partner on Covid-19 Alert System  One comment - (Comments are closed)  Joint ventures/collaborations, New products  biomedical, biotechnology, Covid-19, engineering, Europe, genomics, health care, life sciences, mathematics, medical device, physical sciences, U.K. 
A company using artificial intelligence to design drugs for personalized treatments is partnering with drug maker Sanofi in a deal valued at $5.3 billion. . . . → Read More: Sanofi Partners in $5.3B Precision Drug Discovery Deal One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, cancer, chemistry, Europe, genomics, life sciences, mathematics, pharmaceuticals, physical sciences, U.K. 
A new company developing a therapy using light-sensitive proteins for treating an inherited eye disorder is raising $6 million in seed funds. . . . → Read More: Optogenetics Start-Up Raises $6M for Retinal Therapy Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, preclinical, U.K., university, venture capital 
GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders. . . . → Read More: Oxford, GSK Partner on New Tech for Neuro Diseases One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, genomics, grant, life sciences, mathematics, medical device, pharmaceuticals, physical sciences, U.K., university 
Alphabet, the parent company of Google, is forming a new enterprise using artificial intelligence techniques to discover new protein-based drugs. . . . → Read More: Alphabet Forms AI Drug Discovery Company Comments are closed New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, Europe, genomics, life sciences, mathematics, pharmaceuticals, physical sciences, U.K. 
A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray Comments are closed Intellectual property, New products biomedical, chemistry, engineering, licensing, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, U.K. 
A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round. . . . → Read More: Psychedelic Therapy Company Raises $80M in New Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, clinical trials, entrepreneurs, equity, investment, life sciences, pharmaceuticals, psychiatric, U.K., venture capital
A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer’s disease and other forms of dementia. . . . → Read More: Alzheimer’s Digital Biomarkers Project Gains New Funds Comments are closed Finance, New products biomarkers, biomedical, engineering, grant, life sciences, mathematics, medical device, software, U.K., university |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
